Verdiva Bio Revenue

Biotechnology Research • London, England, United Kingdom • 51-100 Employees

Verdiva Bio revenue & valuation

Annual revenue	$4,619,970
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$14,800,000
Total funding	$411,000,000

Key Contacts at Verdiva Bio

Khurem Farooq

Chief Executive Officer

James Lloyd

Executive Director, Head Of Operational Services

Catherine Baldridge

Executive Director, Head Of Safety

Tapan Maniar

Chief Business Officer & Co-Founder

Pingjun Wei

Director, Bd And Alliance Management

Jane Hughes

President R&D & Co-Founder

Sara Harmon

Director Of Clinical Operations

Silvina Baudino

Executive Director Clinical Site Strategy

James Francis

Executive Director, Head Of Discovery

Courtney Hill

Executive Director Of Manufacturing

Company overview

Headquarters	London, England, United Kingdom
Website	verdivabio.com
NAICS	541714
Employees	51-100
Socials

Verdiva Bio Email Formats

Verdiva Bio uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@verdivabio.com), used 56.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@verdivabio.com	56.9%
{first initial}.{last name}	j.doe@verdivabio.com	43.1%

About Verdiva Bio

Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options. Our most advanced therapy is VRB-101, an oral GLP-1 peptide in clinical development that has demonstrated best-in-class efficacy potential in a phase 1 study in Australia, which also confirmed the viability of once-weekly dosing. We are also developing a portfolio of amylin molecules, including oral and subcutaneous agonists, and other undisclosed programs that offer the potential for enhanced efficacy, improved tolerability, and healthier weight loss. The Verdiva team will harness the emerging science in gut-brain biology and leverage their history of successful drug development to advance novel therapeutic options aiming to transform the lives of millions living with obesity worldwide. For more information, please visit www.verdivabio.com.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director

Vice President

C-Suite

Employees by Department

Verdiva Bio has 28 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Verdiva Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-02-09	4	$411,000,000

Funding Insights

$411,000,000

Total funding amount

$411,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Verdiva Bio is located in London, England, GB.

Verdiva Bio generates an estimated annual revenue of $4,619,970. This revenue figure reflects the company's market position and business performance in its industry.

Verdiva Bio has an estimated valuation of $14,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Verdiva Bio has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Verdiva Bio has raised a total of $411,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.